Mark Hancock, co-founder and Executive Vice Chairman of $PACS Group, Inc., sold 61,931 shares of $PACS (NYSE: $PACS) on June 26, 2026, across two open-market transactions that together totaled approximately $2.51 million. The larger of the two legs — 61,731 shares at an average price of $40.4964 per share — accounted for roughly $2.50 million of that figure. A second, smaller transaction of 200 shares at $41.01 per share added approximately $8,200 more. Both transactions were reported in a single Form 4 filed the same day.
The June 26 activity followed an even larger sale the prior session. On June 25, Hancock sold 138,069 shares at an average price of $40.3255 per share, generating approximately $5.57 million — the largest single insider sale on record in the database for this ticker. Taken together, Hancock's June 25–26 transactions span roughly $8.08 million in total value across three separate trade legs, all captured under the same accession number. After the final June 26 transaction settled, Hancock's reported position stood at 54,102,597 shares.
The broader $PACS insider trading picture shows other officers have also been active. John Todd Mitchell, the company's Chief Legal Officer and Secretary, sold shares in two separate filing periods. In May 2026, Mitchell executed four transactions between May 15 and May 18, at prices ranging from roughly $37.91 to $38.74 per share, for a combined total of approximately $3.02 million. Before that, in November 2025, Mitchell sold 159,556 shares at approximately $29.89 per share for about $4.77 million — filed two days after the trade date. COO Joshua Jergensen also reported an open-market sale of 36,335 shares at $34.28 per share on March 13, 2026, for roughly $1.25 million, with that Form 4 filed four days later.
$PACS Group operates in the Health Care sector. Director Evelyn S. Dilsaver stands out as the sole buyer among recent $PACS Form 4 filers, having purchased 16,724 shares on November 24, 2025, at approximately $29.90 per share for roughly $500,000 — the same date as Mitchell's November sale. Hancock's position of more than 54 million shares following this week's transactions continues to make him the company's largest disclosed insider holder by a wide margin.